
© 2024 Der Aktionär
Realtime | Geld | Brief | Zeit |
---|---|---|---|
21,950 | 22,190 | 25.04. | |
21,885 | 22,120 | 25.04. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | Viking Therapeutics Stock May Struggle After As-Expected Report | ||
Do | Viking Therapeutics, Inc. - 10-Q, Quarterly Report | ||
Do | Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips | ||
Do | Viking Therapeutics targets 2025 Phase 3 trials for VK2735 obesity program with promising results | ||
Do | Viking Therapeutics Stock Dips After Q1 EPS Miss: Details |